Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis

被引:0
|
作者
P. Wainwright
E. Scorletti
C. D. Byrne
机构
[1] University Hospital Southampton,Clinical Biochemistry
[2] University Hospital Southampton,Chemical Pathology and Metabolic Medicine, Department of Laboratory Medicine, D
[3] University of Southampton,Level Pathology Block
[4] University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust,Human Development and Health Academic Unit, Faculty of Medicine
来源
Current Diabetes Reports | 2017年 / 17卷
关键词
Diabetes; Obesity; Hepatocellular carcinoma; Risk factors; Pathogenesis; Non-alcoholic fatty liver disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
    Wainwright, P.
    Scorletti, E.
    Byrne, C. D.
    [J]. CURRENT DIABETES REPORTS, 2017, 17 (04)
  • [2] Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
    Asmaa Ibrahim Gomaa
    Shahid A Khan
    Mireille B Toledano
    Imam Waked
    Simon D Taylor- Robinson
    [J]. World Journal of Gastroenterology, 2008, (27) : 4300 - 4308
  • [3] Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
    Gomaa, Asmaa Ibrahim
    Khan, Shahid A.
    Toledano, Mireille B.
    Waked, Imam
    Taylor-Robinson, Simon D.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (27) : 4300 - 4308
  • [4] Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    [J]. LIVER INTERNATIONAL, 2018, 38 (11) : 2018 - 2027
  • [5] NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
    Bugianesi E.
    Vanni E.
    Marchesini G.
    [J]. Current Diabetes Reports, 2007, 7 (3) : 175 - 180
  • [6] The Role of Type 2 Diabetes Mellitus-Related Risk Factors and Drugs in Hepatocellular Carcinoma
    Mai, Yuhua
    Meng, Liheng
    Deng, Ganlu
    Qin, Yingfen
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 159 - 171
  • [7] Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
    Nevola, Riccardo
    Tortorella, Giovanni
    Rosato, Valerio
    Rinaldi, Luca
    Imbriani, Simona
    Perillo, Pasquale
    Mastrocinque, Davide
    La Montagna, Marco
    Russo, Antonio
    Di Lorenzo, Giovanni
    Alfano, Maria
    Rocco, Maria
    Ricozzi, Carmen
    Gjeloshi, Klodian
    Sasso, Ferdinando Carlo
    Marfella, Raffaele
    Marrone, Aldo
    Kondili, Loreta Anesti
    Esposito, Nicolino
    Claar, Ernesto
    Cozzolino, Domenico
    [J]. BIOLOGY-BASEL, 2023, 12 (07):
  • [8] Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Qi, Yueying
    Fan, Lirong
    Ran, Decong
    Xu, Jieda
    Wang, Yuansong
    Wu, Jin
    Zhang, Zhongyong
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [9] Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes
    Si, Won Keun
    Chung, Jung Wha
    Cho, Junhyeon
    Baeg, Joo Yeong
    Jang, Eun Sun
    Yoon, Hyuk
    Kim, Jaihwan
    Shin, Cheol Min
    Park, Young Soo
    Hwang, Jin-Hyeok
    Jeong, Sook-Hyang
    Kim, Nayoung
    Lee, Dong Ho
    Lim, Soo
    Kim, Jin-Wook
    [J]. PLOS ONE, 2016, 11 (06):
  • [10] Metformin and Risk of Hepatocellular Carcinoma in Taiwanese Patients with Type 2 Diabetes
    Tseng, Chin-Hsiao
    [J]. DIABETES, 2018, 67